Astrana Health Inc. Common Stock (ASTH) is a publicly traded Healthcare sector company. As of May 21, 2026, ASTH trades at $38.63 with a market cap of $1.93B and a P/E ratio of 82.85. ASTH moved -1.22% today. Year to date, ASTH is +41.46%; over the trailing twelve months it is +43.13%. Its 52-week range spans $18.08 to $63.20. Analyst consensus is strong buy with an average price target of $41.57. Rallies surfaces ASTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Astrana Health Appoints George Christides to Lead Population Health Across 1.55M Patients: Astrana Health named George Christides as Interim National Medical Director to lead population health, care management and navigation across its national platform. The company supports over 20,000 providers and approximately 1.55 million patients in value-based care arrangements using its AI-powered, physician-centric technology to drive growth and outcomes.
| Metric | Value |
|---|---|
| Price | $38.63 |
| Market Cap | $1.93B |
| P/E Ratio | 82.85 |
| EPS | $0.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $63.20 |
| 52-Week Low | $18.08 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.18B |
| Net Income | $24.08M |
| Gross Margin | 0.00% |
9 analysts cover ASTH: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.57.